Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
The PGDx elio tissue complete test is a Viable Alternative to Send-Out Testing for Comprehensive Genomic Profiling
Request Your Free White Paper Now:

"The PGDx elio tissue complete test is a Viable Alternative to Send-Out Testing for Comprehensive Genomic Profiling"

Next-generation sequencing has emerged as the preferred approach for comprehensive genomic profiling in cancer.

Less than 20 percent of late-stage cancer patients receive the molecular tumor testing necessary to help guide treatment strategies. PGDx elio tissue complete, an FDA 510(k) cleared and CE-IVD marked decentralized pan solid tumor CGP test, demonstrated high concordance with the Foundation Medicine FoundationOne test.

This white paper from PGDx presents results from a study comparing the PGDx elio tissue complete Test to send-out testing for comprehensive genomic profiling, finding it to be a viable local testing solution for molecular laboratories and may thereby increase patient access to accurate tumor profiling at a faster turnaround time.


Offered Free by: PGDx
See All Resources from: PGDx

Recommended for Professionals Like You:

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.